Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nivolumab for High-Grade Cervical Dysplasia
NCT03808168Phase 2Withdrawn
- Sponsor
- UT Southwestern Medical Center
- Start
- Jan 2019
- Primary completion
- Jun 2019
01
Overview
A Phase 2 trial of nivolumab in cervical dysplasia (CIN), sponsored by UT Southwestern Medical Center. Planned start Jan 2019; status: withdrawn.
02
Drugs
03
Conditions
cervical dysplasia (CIN)
Beyond the preview
Go deeper on NCT03808168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03808168.